Evaluation of CCN3 as an Inflammatory Marker of Disease Activity in Rheumatoid Arthritis Patients
(2023). Evaluation of CCN3 as an Inflammatory Marker of Disease Activity in Rheumatoid Arthritis Patients. EKB Journal Management System, 92(1), 6185-6190. doi: 10.21608/ejhm.2023.313888
. "Evaluation of CCN3 as an Inflammatory Marker of Disease Activity in Rheumatoid Arthritis Patients". EKB Journal Management System, 92, 1, 2023, 6185-6190. doi: 10.21608/ejhm.2023.313888
(2023). 'Evaluation of CCN3 as an Inflammatory Marker of Disease Activity in Rheumatoid Arthritis Patients', EKB Journal Management System, 92(1), pp. 6185-6190. doi: 10.21608/ejhm.2023.313888
Evaluation of CCN3 as an Inflammatory Marker of Disease Activity in Rheumatoid Arthritis Patients. EKB Journal Management System, 2023; 92(1): 6185-6190. doi: 10.21608/ejhm.2023.313888